ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

FASENRA
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

FASENRA Rx

Generic Name and Formulations:
Benralizumab 30mg/mL; soln for SC inj; preservative-free.

Company:
AstraZeneca Pharmaceuticals

Therapeutic Use:

Indications for FASENRA:

As add-on maintenance treatment of severe asthma in patients ≥12yrs old, and with an eosinophilic phenotype.

Limitations Of use:

Not for treating other eosinophilic conditions. Not for relief of acute bronchospasm or status asthmaticus.

Adult:

Give by SC inj into upper arm, thigh, or abdomen. 30mg once every 4 weeks for the first 3 doses, then once every 8 weeks thereafter.

Children:

Not established.

Warnings/Precautions:

Not for treating acute asthma symptoms or exacerbations. Discontinue if hypersensitivity reactions occur. Treat pre-existing helminth infections before initiating therapy; discontinue Fasenra if treatment-resistant infection occurs while on therapy until resolves. Avoid abrupt discontinuation of systemic or inhaled corticosteroids; reduce dose gradually upon Fasenra initiation, if appropriate. Reduction may be associated with systemic withdrawal symptoms and/or unmask previously suppressed conditions. Pregnancy. Nursing mothers.

Pharmacological Class:

Interleukin-5 antagonist.

Adverse Reactions:

Headache, pharyngitis, pyrexia, hypersensitivity reactions.

Generic Availability:

NO

How Supplied:

Single-dose prefilled syringe—1

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs